Display options
Cite
Spasovska K, Grozdanovski K, Milenkovic Z, et al. Evaluation of severity scoring systems in patients with severe community acquired pneumonia. Rom J Intern Med. 2021;59(4):394-402doi: 10.2478/rjim-2021-0025.
Spasovska, K., Grozdanovski, K., Milenkovic, Z., Bosilkovski, M., Cvetanovska, M., Kuzmanovski, N., Kapsarov, K., & Atanasovska, E. (2021). Evaluation of severity scoring systems in patients with severe community acquired pneumonia. Romanian journal of internal medicine = Revue roumaine de medecine interne, 59(4), 394-402. https://doi.org/10.2478/rjim-2021-0025
Spasovska, Katerina, et al. "Evaluation of severity scoring systems in patients with severe community acquired pneumonia." Romanian journal of internal medicine = Revue roumaine de medecine interne vol. 59,4 (2021): 394-402. doi: https://doi.org/10.2478/rjim-2021-0025
Spasovska K, Grozdanovski K, Milenkovic Z, Bosilkovski M, Cvetanovska M, Kuzmanovski N, Kapsarov K, Atanasovska E. Evaluation of severity scoring systems in patients with severe community acquired pneumonia. Rom J Intern Med. 2021 Nov 20;59(4):394-402. doi: 10.2478/rjim-2021-0025. Print 2021 Dec 01. PMID: 34182618.
Copy Download .nbib Format: NLM
Share it on

Rom J Intern Med. 2021 Nov 20;59(4):394-402. doi: 10.2478/rjim-2021-0025. Print 2021 Dec 01.

Evaluation of severity scoring systems in patients with severe community acquired pneumonia.

Romanian journal of internal medicine = Revue roumaine de medecine interne

Katerina Spasovska, Krsto Grozdanovski, Zvonko Milenkovic, Mile Bosilkovski, Marija Cvetanovska, Nikola Kuzmanovski, Kosta Kapsarov, Emilija Atanasovska

Affiliations

  1. University Clinic for Infectious Diseases, Faculty of Medicine, University of Ss Cyril and Methodius, Bul. Majka Tereza br 17, 1000 Skopje, North Macedonia.
  2. Institute of Preclinical and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Ss Cyril and Methodius, ul. 50ta Divizija 6, 1000 Skopje, Republic of North Macedonia.

PMID: 34182618 DOI: 10.2478/rjim-2021-0025

[No abstract available.]

© 2021 Katerina Spasovska et al., published by Sciendo.

Keywords: community-acquired pneumonia; intensive care; outcome; prognosis; severity scores

References

  1. 1. ASHLEY C. RIDER, BRADLEY W. FRAZEE. Community-acquired pneumonia. Emerg Med Clin North Am. 2018 Nov; 36(4): 665–683. - PubMed
  2. 2. PRINA E, RANZANI OT, TORRES A. Community-acquired pneumonia. Lancet. 2015 Sep 12;386(9998):1097–108. - PubMed
  3. 3. MUSHER DM, THORNER AR. Community-acquired pneumonia. N Engl J Med. 2014 Oct 23; 371(17):1619–28. - PubMed
  4. 4. JOSE GARNACHO-MONTERO, IRENE BARRERO-GARCÍA, MARIA DE GRACIA GÓMEZ-PRIETO & IGNACIO MARTÍN-LOECHES. Severe community-acquired pneumonia: current management and future therapeutic alternatives, Expert Review of Anti-infective Therapy, 2018 Sept;16(9):667–677. - PubMed
  5. 5. MORGAN AJ, GLOSSOP AJ. Severe community-acquired pneumonia.BJA Education.2016; 16(5): 167–172. - PubMed
  6. 6. EWIG S, SCHAFER H, TORRES A. Severity assessment in community-acquired pneumonia. Eur Respir J. 2000; 16(6):1193–201. - PubMed
  7. 7. NEUHAUS T, EWIG S. Defining severe community-acquired pneumonia. Med Clin North Am. 2001;85(6):1413–25. - PubMed
  8. 8. METLAY JP et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67. - PubMed
  9. 9. FINE MJ, AUBLE TE, YEALY DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997; 336:243–250. - PubMed
  10. 10. British Thoracic Society Standards of Care Committee. BTS Guidelines for the Management of Community Acquired Pneumonia in Adults. Thorax. 2001;56 Suppl 4: IV1-64. - PubMed
  11. 11. ESPAÑA PP, CAPELASTEGUI A, GORORDO I, ESTEBAN C, ORIBE M, ORTEGA M, BILBAO A, QUINTANA JM. Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med. 2006 Dec 1;174(11):1249–56. - PubMed
  12. 12. NIEDERMAN MS, MANDELL LA, ANZUETO A et al. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001 Jun; 163(7):1730–54. - PubMed
  13. 13. LE GALL JR, LEMESHOW S, SAULNIER F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993 Dec 22-29;270(24):2957–63. - PubMed
  14. 14. LAMBDEN S, LATERRE PF, LEVY MM, FRANCOIS B. The SOFA score-development, utility and challenges of accurate assessment in clinical trials. Crit Care. 2019 Nov 27;23(1):374. - PubMed
  15. 15. GODINJAK A, IGLICA A, RAMA A, TANČICA I, JUSUFOVIĆ S, AJANOVIĆ A, KUKULJAC A. Predictive value of SAPS II and APACHE II scoring systems for patient outcome in a medical intensive care unit. Acta Med Acad. 2016 Nov;45(2):97–103. - PubMed
  16. 16. SALLUH JI, SOARES M. ICU severity of illness scores: APACHE, SAPS and MPM. Curr Opin Crit Care. 2014 Oct;20(5):557–65. - PubMed
  17. 17. GROZDANOVSKI K, MILENKOVIC Z, STOJOVSKA KALAMARAS P at al. Findings after the analysis of the structure of the patients hospitalized in a six-year period. MMR 2003;53 (Supp 37):178–179. - PubMed
  18. 18. MORTENSEN EM, COLEY CM, SINGER DE, et al. Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med 2002;162: 1059–1064. - PubMed
  19. 19. KOTHE H, BAUER T, MARRE R, SUTTORP N, WELTE T, DALHOFF K; Competence Network for Community-Acquired Pneumonia study group. Outcome of community acquired pneumonia: influence of age, residence status and antimicrobial treatment. Eur Respir J. 2008 Jul;32(1):139–46. - PubMed
  20. 20. PATTERSON C.M., LOEBINGER M.R. Community acquired pneumonia: Assessment and treatment. Clin Med (Lond). 2012 Jun;12(3):283–6. - PubMed
  21. 21. KOLDITZ M, EWIG S, KLAPDOR B, SCHUTTE H, WINNING J, RUPP J et al. Community-acquired pneumonia as medical emergency: predictors of early deterioration. Thorax 2015; 70: 551–58. - PubMed
  22. 22. BRANCARTI FL, CHOW JW, WAGENER MM, et al. Is pneumonia really the old man’s friend? Two-year prognosis after community-acquired pneumonia. Lancet 1993; 342:30–33. - PubMed
  23. 23. BAHLIS LF, DIOGO LP, FUCHS SC. Charlson Comorbidity Index and other predictors of in-hospital mortality among adults with community-acquired pneumonia. J Bras Pneumol. 2021 Feb 24;47(1):e20200257. - PubMed
  24. 24. WESEMANN T, NÜLLMANN H, PFLUG MA, HEPPNER HJ, PIENTKA L, THIEM U. Pneumonia severity, comorbidity and 1-year mortality in predominantly older adults with community-acquired pneumonia: a cohort study. BMC Infect Dis. 2015;15:2. - PubMed
  25. 25. MULLER B, HARBARTH S, STOLZ D, BINGISSER R, MUELLER C, LEUPPI J, NUSBAUMER C, TAMM M, CHRIST-CRAIN M. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis. 2007; 7:10. - PubMed
  26. 26. ABDEL AZIZ AO, ABDEL FATTAH M T, MOHAMED AH, ABDEL AZIZ MO, MOHAMMED MS. Mortality predictors in patients with severe community-acquired pneumonia requiring ICU admission. Egypt J Bronchology, 2016; 10 (2): 155–161. - PubMed
  27. 27. ITO A, ISHIDA T, TOKUMASU H, WASHIO Y, YAMAZAKI A, ITO Y, TACHIBANA H. Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort. BMC Pulm Med. 2017 May 2;17(1):78. - PubMed
  28. 28. NING P, ZHENG Y, LUO Q, LIU X, KANG Y, ZHANG Y, ZHANG R, XU Y, YANG D, XI W, WANG K, CHEN Y, AN S, GAO Z. Metabolic profiles in community-acquired pneumonia: developing assessment tools for disease severity. Crit Care. 2018 May 14;22(1):130. - PubMed
  29. 29. HUANG Y, LIU A, LIANG L, JIANG J, LUO H, DENG W, LIN G, WU M, LI T, JIANG Y. Diagnostic value of blood parameters for community-acquired pneumonia. Int Immunopharmacol. 2018 Nov;64:10–15. - PubMed
  30. 30. UGAJIN M, YAMAKI K, HIRASAWA N, YAGI T. Predictive values of semi-quantitative procalcitonin test and common biomarkers for the clinical outcomes of community-acquired pneumonia. Respir Care. 2014;59: 564–73. - PubMed
  31. 31. SIBILA O, RESTREPO MI. Biomarkers in community-acquired pneumonia: still searching for the one. Eur Respir J. 2019 Feb 28; 53(2):1802469. - PubMed
  32. 32. AKAGI T, NAGATA N, MIYAZAKI H, HARADA T, TAKEDA S, YOSHIDA Y, WADA K, FUJITA M, WATANABE K. Procalcitonin is not an independent predictor of 30-day mortality, albeit predicts pneumonia severity in patients with pneumonia acquired outside the hospital. BMC Geriatr. 2019 Jan 7;19(1):3. - PubMed
  33. 33. AUJESKY D, AUBLE TE, YEALY DM, STONE RA, OBROSKY DS, MEEHAN TP, et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med 2005; 118: 384–92. - PubMed
  34. 34. MAN SY, LEE N, IP M, ANTONIO GE, CHAU SS, MAK P, et al. Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong. Thorax 2007; 62: 348–53. - PubMed
  35. 35. BUISING KL, THURSKY KA, BLACK JF, MACGREGOR L, STREET AC, KENNEDY MP, et al. A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia. Thorax 2006; 61: 419–24. - PubMed
  36. 36. ESPANA PP, CAPELASTEGUI A, QUINTANA JM, BILBAO A, DIEZ R, PASCUAL S, et al. Validation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumonia. J Infect 2010; 60: 106–13. - PubMed
  37. 37. CHALMERS JD, MANDAL P, SINGANAYAGAM A, AKRAM AR, CHOUDHURY G, SHORT PM, HILL AT: Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis. Intensive Care Med 2011, 37:1409–1420. - PubMed
  38. 38. MARTI et al. Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis. Critical Care 2012, 16: R141. - PubMed
  39. 39. KĄDZIOŁKA I, ŚWISTEK R, BOROWSKA K, TYSZECKI P, SEREDNICKI W. Validation of APACHE II and SAPS II scales at the intensive care unit along with assessment of SOFA scale at the admission as an isolated risk of death predictor. Anaesthesiol Intensive Ther. 2019;51(2):107-111. - PubMed
  40. 40. ALICI IO, CAPAN N, ERTURK A, CANBAKAN S. Comparison of Severity Scoring Systems in Community-Acquired Pneumonia. Eurasian J Pulmonol 2015; 17: 15–21. - PubMed
  41. 41. HANIFFA R, ISAAM I, DE SILVA AP, DONDORP AM, DE KEIZER NF. Performance of critical care prognostic scoring systems in low and middle-income countries: a systematic review. Crit Care. 2018 Jan 26;22(1):18. - PubMed
  42. 42. KEEGAN MT, GAJIC O, AFESSA B. Severity of illness scoring systems in the intensive care unit. Crit Care Med. 2011 Jan;39(1):163–9. - PubMed

Publication Types